OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Improving these processes involves modifying various factors, including cell line selection, media formulation, and bioreactor settings. A key goal is to maximize antibody titer while minimizing production expenses an